INT MEDICAL Reports Annual Profit Increase of 22.43% to 233 Million Yuan

Stock News
03/27

INT MEDICAL (01501) announced its financial results for the year ended December 31, 2025. The company recorded revenue of 1.065 billion yuan, representing a year-on-year increase of 25.06%. Gross profit reached 637 million yuan, up 18.44% compared to the previous year. Net profit amounted to 233 million yuan, a growth of 22.43%. Earnings per share were 1.26 yuan. The board proposed a dividend of 0.23 yuan per share.

According to the announcement, the increase in revenue was driven by a rise in new customers and business consolidation. During the reporting period, revenue from the sales of interventional medical devices was approximately 968 million yuan, an increase of about 25.17% compared to approximately 773 million yuan in the year ended December 31, 2024.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10